Современные возможности симптоматической терапии дизурии


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

Одним из распространенных состояний в урологии является дизурия, которая хотя и не относится к самостоятельным заболеваниям, но сопровождает широкий спектр урологических патологий как инфекционного, так и неинфекционного генеза. Под дизурией традиционно понимают чувство дискомфорта, жжения или ощущение боли во время мочеиспускания. Несмотря на значительное снижение качества жизни данной категории пациентов, в рутинной клинической практике зачастую проводится только патогенетическое лечение основного заболевания, в то время как проявления дизурии могут оставаться без должного внимания. В данном обзоре литературы рассмотрены современные возможности симптоматической терапии дизурии.

Полный текст

Доступ закрыт

Об авторах

А. З Винаров

ФГАОУ ВО «Первый МГМУ им. И. М. Сеченова» Минздрава России (Сеченовский Университет)

Email: avinarov@mail.ru
д.м.н., профессор, Институт урологии и репродуктивного здоровья человека

Л. Г Спивак

ФГАОУ ВО «Первый МГМУ им. И. М. Сеченова» Минздрава России (Сеченовский Университет)

Email: leonid.spivak@gmail.com
доцент, Институт урологии и репродуктивного здоровья человека

Список литературы

  1. Gerber G.S., Brendler C.B. Evaluation of the urologic patient: history, physical examination, and urinalysis. In: Wein A.J., et al.; eds. Campbell-Walsh Urology. 10th ed. Philadelphia, Pa.: Elsevier Saunders 2012: 75-76.
  2. Bremnor J.D., Sadovsky R. Evaluation of dysuria in adults. Am Fam Physician 2002;65(8):1589-1596.
  3. Hanno P., Nordling J., Fall M. Bladder pain syndrome. Med Clin North Am 2011;95(1):55-73.
  4. Richardson D.A. Dysuria and urinary tract infections. Obstet Gynecol Clin North Am 1990;17:881-888.
  5. Sommer P., Nielsen K.K., Bauer T, et al. Voiding patterns in men evaluated by a questionnaire survey. Br J Urol 1990;65:155-160.
  6. Wyndaele J.J., De Wachter S. The sensory bladder (1): an update on the different sensations described in the lower urinary tract and the physiological mechanisms behind them. Neurourol Urodyn 2008;27(4):274-278.
  7. Kulkarni S.K. Antispasmodics - A new perspective. JAMA India 2001;4(8):119-121.
  8. Roxburgh C., Cook J., Dublin N. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. Cochrane Database Syst Rev 2007;(3):CD003190.
  9. Chapple C.R., Khullar V., Gabriel Z., Muston D., Bitoun C.E., Weinstein D. The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis. Eur Urol 2008; 54(3): 543-562.
  10. Sri Sivalingam, Manoj Monga. Management of Ureteral Stent Discomfort in Contemporary Urology Practice. Urology Practice 1 (2014), 141-145.
  11. Deliveliotis C., Chrisofos M., Gougousis E. et al. Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology. 2006;67:35.
  12. Beddingfield R., Pedro R.N., Hinck B. et al. Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol 2009; 181: 170.
  13. Dellis A.E., Keeley F.X. Jr, Manolas V. et al. Role of a-blockers in the treatment of stent-related symptoms: a prospective randomized control study. Urology 2014; 83: 56.
  14. Nakada S.Y., Jerde T.J., Bjorling D.E. et al. Selective cyclooxygenase-2 inhibitors reduce ureteral contraction in vitro: a better alternative for renal colic? J Urol 2000; 163: 607.
  15. Kyungtae Ko, Won Ki Lee, Cheol Young Oh et al. Is A Combination of Antibiotics and Non-Steroidal Anti-Inflammatory Drugs More Beneficial Than Antibiotic Monotherapy For The Treatment of Female Acute Uncomplicated Cystitis? A Randomized Controlled Pilot Study. Female Urology 2018; 15(06):365-369.
  16. Gagyor I., Bleidorn J., Kochen M.M., Schmiemann G., Wegscheider K., Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. BMJ. 2015;23;351:h6544.
  17. Kulchavenya E. Acute uncomplicated cystitis: is antibiotic unavoidable? Ther Adv Urol 2018;10(9):257-262.
  18. Lars Bjerrum, Morten Lindbxk. Which treatment strategy for women with symptoms of urinary tract infection? BMJ 2015; 351:h6888. Published online 2015 Dec 29.
  19. Yan H., Wang Y., Sun R., Cui Y. The Efficacy of Antimuscarinics Alone or in Combination with Alpha-Blockers for the Treatment of Ureteral Stent-Related Symptoms: A Systematic Review and Meta-Analysis. Urol Int 2017;99(1):6-13.
  20. Gupta O.P., Aggarwal K.K. Role of Phenazopyridine in Urinary Tract Infections. Indian Journal of Clinical Practice 2012; 22(9):437-441.
  21. Kinnman E., Nygards E.B., Hansson P. Peripheral alpha-adrenoreceptors are involved in the development of capsaicin induced ongoing and stimulus evoked pain in humans. Pain 1997;69:79-85.
  22. Ye Z.Q., Lan R.Z., Yang W.M. et al. Tamsulosin treatment of chronic non-bacterial prostatitis. J. Int. Med. Res. 2008; 36(2):244-252.
  23. Lamb A.D., Vowler S.L., Johnston R., Dunn N., Wiseman O.J. Metaanalysis showing the beneficial effect of alpha-blockers on ureteric stent discomfort. BJU Int. 2011;108(11):1894-1902.
  24. Yakoubi R., Lemdani M., Monga M., Villers A., Koenig P. Is there a role for alpha-blockers in ureteral stent related symptoms? A systematic review and meta-analysis. J Urol. 2011;186(3):928-934.
  25. Kwon J.K., Cho K.S., Oh C.K., Kang D.H., Lee H, Ham W.S., Choi Y.D., Lee J.Y. The beneficial effect of alpha-blockers for ureteral stent-related discomfort: systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placebo. BMC Urol. 2015;24:15-55.
  26. Vassilis Pergialiotis, Pantelis Arnos, Michael N Mavros, Eleni Pitsouni, Stavros Athanasiou, Matthew E Falagas. Urinary tract analgesics for the treatment of patients with acute cystitis: where is the clinical evidence? Expert Rev. Anti Infect. Ther 2012; 10(8), 875-879.
  27. Jenkins G.L., Hartung W. The Chemistry of Organic Medicinal Products. Uchebnoe posobie. M.: Gosudarstvennoe izdatel’stvo inostrannoi literatury; 1949. Russian (Дженкинс Г.Н, Хартунг У. Химия органических лекарственных препаратов. Учебное пособие. М.: Государственное издательство иностранной литературы; 1949).
  28. Ramesh Hotchandani, Aggarwal K.K. Urinary Tract Infections in Women. Indian Journal of Clinical Practice 2012; 23(4):187-192.
  29. https://clincalc.com/drugstats/drugs/phenazopyridine. Доступ от 13.12.2018
  30. Thomas B.H., Whitehouse L.W., Solomonraj G., Paul C.J. Metabolism and disposition of phenazopyridine in rat. Xenobiotica 1993;23(2):99-105.
  31. Naoki Aizawa, Jean-Jacques Wyndaele. Effects of phenazopyridine on rat bladder primary afferent activity, and comparison with lidocaine and acetaminophen. Neurourol. Urodynam 2010;29: 1445-1450.
  32. Kirwin T.J., Lowsley A.S., Menning J. The effects of Pyridium in certain urogenital infections. Am J Surg 1943;62:330-335.
  33. Zelenitsky S.A., Zhanel G.G. Phenazopyridine in urinary tract infections, Ann Pharmacother. 1996;30(7-8):866-888.
  34. Trickett P.C. Ancillary use of phenazopyridine (Pyridium) in urinary tract infections. CUIT Ther Res 1970;12:441-445.
  35. Gould S. Clinical comparison of flavoxate and phenazopyridine. Urology 1975;5:612-615.
  36. Gilderman L., Hendry D., Patrick K. Evaluation of the efficacy of phenazopyridine Hydrochloride (Formula PD-F-0016) as a urinary analgesic in women with urinary tract infections. FDA’s Dockets Management. Protocol Number: 99-001-P (2001). www.fda.gov
  37. Deepalatha C., Deshpande N. A comparative study of phenazopyridine (pyridium) and cystone as short-term analgesic in uncomplicated urinary tract infection. Int J Pharm Pharm Sci 2011;3(Suppl 2):224-226.
  38. Marceli'n-Jimenez G., Angeles A.P., Martinez-Rossier L. et al. Ciprofloxacin Bioavailability is Enhanced by Oral Co-Administration with Phenazopyridine Clin. Drug Investig. 2006; 26:323
  39. Kasymov A.A. Use of Uropirin for treatment ofpatients with inflammatory diseases of lower urinary tract. Medicina 2012;5:3. Russian (Касымов А.А. Применение препарата Уропирин в лечении больных с воспалительными заболеваниями нижних мочевых путей. Медицина 2012;5:39).
  40. Fischer K.M., Louie M. Ureteral Stent Discomfort and Its Management. P. Curr Urol Rep, 2018; 19: 64.
  41. Norris R.D., Sur R.L., Springhart W.P., Marguet C.G., Mathias B.J., Pietrow P.K., Albala D.M., Preminger G.M. A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Urology 2008;71(5):792-795.
  42. Nazarko L. Bladder pain from indwelling urinary catheterization: case study. Br J Nurs 2007;16(9):511-2,514.
  43. Yu C.H., Wang C.H., Chang C.C. Chocolate colored blood with normal artery oxygen: methemoglobinemia related to phenazopyridine. Am. J. Med. Sci 2011; 341(4): 337.
  44. Haigh C., Dewar J.C. Multiple adverse effects of pyridium: a case report. South. Med. J 2006; 99(1): 90-92.
  45. Vega J. Acute renal failure caused by phenazopyridine. Rev. Med. Chil 2003;131(5):541-544.
  46. Rivas R., Martinez Torres A., Bohorques R., Martinez Albelo I. Acute kidney failure caused by phenazopyridine overdose. Nefrologia 2001; 21(1):97-98.
  47. Siddiqui M.A. Chronic severe hemolytic anemia from phenazopyridine. Ann. Intern. Med 1995; 122(2): 156-157.
  48. Thomas R.J., Doddabele S., Karnad A.B. Chronic severe hemolytic anemia related to surreptitious phenazopyridine abuse. Ann. Intern. Med 1994;121(4):308.
  49. Shahani L., Sattovia S. Acquired methaemoglobinaemia related to phenazopyridine ingestion. BMJ Case Reports. 2012;2012.
  50. Shatila W., Clark A. Unexplained hypoxia in a woman presenting with acute on chronic abdominal pain. Am J Med. 2013; 126:e1-2.
  51. Daly J.S., Hultquist D.E., Rucknagel D.L. Phenazopyridine induced methaemoglobinaemia associated with decreased activity of erythrocyte cytochrome b5 reductase. J Med Genet 1983;20:307-309.
  52. Banimahd F., Loo, T., Amin M., Ahadiat O. R., Chakravarthy B., Lotfipour S. A Rare but Important Clinical Presentation of Induced Methemoglobinemia. The western journal of emergency medicine 2016; 17(5): 627-629.
  53. Holmes I., Berman N., Domingues V. Acute Renal Failure and Jaundice without methemoglobinemia in a Patient with Phenazopyridine Overdose: Case Report and Review of the Literature. Case Rep Nephrol. 2014;2014:845372.
  54. Nathan D.M., Siegel A.J., Bunn H.F. Acute methemoglobinemia and hemolytic anemia with phenazopyridine: possible relation to acute renal failure. Arch Intern Med 1977;137(11):1636-1638.
  55. Christensen C.M., Farrar H.C., Kearns G.L. Protracted methemoglobinemia after phenazopyridine overdose in an infant. J Clin Pharmacol 1996;36(2):112-116.
  56. Gold N.A., Bithoney W.G. Methemoglobinemia due to ingestion of at most three pills of pyridium in a 2-year-old: case report and review. J Emerg Med 2003;25(2):143-148.
  57. Jeffery W.H., Zelicoff A.P., Hardy W.R. Acquired methemoglobinemia and hemolytic anemia after usual doses of phenazopyridine. Drug Intell Clin Pharm 1982;16(2):157-159.
  58. Gavish D., Knobler H., Gottehrer.N, Israeli A., Kleinman Y. Methemoglobinemia, muscle damage and renal failure complicating phenazopyridine overdose. Isr J Med Sci 1986;22(1):45-47.
  59. Sand R.E., Edelmann C.M. Jr. Pyridium-induced methemoglobinemia. Report of a case. J Pediatr 1961;58:845-48.
  60. Truman T.L., Dallessio J.J., Weibley R.E. Life-threatening Pyridium Plus intoxication: a case report. Pediatr Emerg Care 1995;11(2):103-16.
  61. Zimmerman R.C., Green E.D., Ghurabi W.H., Colohan D.P. Methemoglobinemia from overdose of phenazopyridine hydrochloride. Ann Emerg Med 1980;9(3):147-149.
  62. Landman J., Kavaler E., Waterhouse R.L. Jr. Acquired methemoglobinemia possibly related to phenazopyridine in a woman with normal renal function. J Urol 1997;158(4):1520-1521.
  63. Conroy J.M., Baker J.D. 3rd, Martin W.J., Bailey M.K., Dorman B.H. Acquired methemoglobinemia from multiple oxidants. South Med J 1993;86(10):1156-1159.
  64. Randazzo G.P., Ford E.A., Glauser F.L. Methemoglobinemia caused by acute overdosage of phenazopyridine. West J Med 1975; 122(5) 427-429.
  65. Crawford S.E., Moon A.E. Jr, Panos T.C., Hooks C.A. Methemoglobinemia associated with pyridium administration; report of a case. J Am Med Assoc 1951 5;146(1):24-25.
  66. Lee M., Bozzo P., Einarson A., Koren G. Urinary tract infections in pregnancy. Can Fam Physician 2008;54(6):853-854.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО «Бионика Медиа», 2019

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах